Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sorin stent

This article was originally published in The Gray Sheet

Executive Summary

Chrono cobalt chrome stent launches in Europe following CE mark receipt April 4. Sorin claims that in comparison to stainless steels stents, Chrono offers better mechanical strength, flexibility and radiopacity. The device features two radiopaque markers at each end to aid in placement at the target lesion as well as a bio-compatible coating to reduce stent thrombosis. In February, the firm launched the Janus Flex tacrolimus-eluting stent in Europe (1"The Gray Sheet" Feb. 27, 2006, In Brief)...

You may also be interested in...



Sorin Group’s next-gen DES

Firm has launched its Janus Flex tacrolimus-eluting Carbostent system in Europe, Sorin announces Feb. 21. With many of the same safety and efficacy components of the company's first-generation product - including a polymer-free design that relies on reservoirs on the stent's outer surface for targeted drug release - the firm claims Janus Flex features an improved catheter tip to facilitate deliverability and conformability in difficult-to-access anatomy...

US FDA Not Changing Assessment Goals Because of Coronavirus-Mandated Telework

Assessment work also isn’t slowing down, the new and generic drug office directors said in and interview, but approval data offers a note of concern.

Abbott Launches Five-Minute POC Rapid COVID-19 Test

Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.

UsernamePublicRestriction

Register

MT023426

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel